InvestorsHub Logo
Followers 1
Posts 269
Boards Moderated 0
Alias Born 05/08/2017

Re: None

Saturday, 07/22/2017 7:32:34 PM

Saturday, July 22, 2017 7:32:34 PM

Post# of 2537
Extra shares are not necessarily a bad thing, however with a FDA approval in hand DVAX can easily raise capital by other means. Also, SD-101 is funded till 2018.

What worries me is if the shares can be placed before the FDA meeting. Let assume the meeting on the 17 ends up approving them and AdComm is positive. Would DVAX announce a new issue BEFORE the FDA meeting?. Or, rather this will happen after the meeting? Or this will happen some time down the road?

I would hate to wait all this time to see a good SP being brought down by delusion just at the "best" time for us long-term investors.

Any thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DVAX News